Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join this 51-minute webinar featuring an unprecedented collaboration between the journals Antimicrobial Agents and Chemotherapy (AAC) and Journal of Infectious Diseases (JID) as part of the inaugural Interdisciplinary Meeting of Antimicrobial Resistance and Innovation (IMARI). Explore the most significant antimicrobial resistance research published in 2025 through expert analysis and discussion with Dr. Ayesha Khan from UC Irvine and Dr. Madison Stellfox from University of Pittsburgh Medical Center. Examine cutting-edge studies covering carbapenemase inhibitors against Acinetobacter species, novel combination therapies for carbapenem-resistant pathogens, daptomycin-loaded nanocarriers for MRSA treatment, antifungal biofilm activity against Candida species, rapid drug sensitivity testing for Mycobacterium tuberculosis using engineered bacteriophages, and host-directed therapeutic approaches. Discover how these breakthrough findings advance the field of antimicrobial resistance research, their clinical implications, and their potential impact on combating one of modern medicine's greatest challenges. Gain insights into the collaborative efforts between the American Society for Microbiology and Infectious Diseases Society of America in addressing global antimicrobial resistance through interdisciplinary research and innovation.
